Lv1
10 积分 2025-07-22 加入
ABS0200 KT501, A CD19, BCMA-DIRECTED T-CELL ENGAGER (TCE), LEADS TO DEEP B-CELL DEPLETION AND MINIMAL CYTOKINE RELEASE IN VIVO
7小时前
待确认
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
Efficient Generation of iPSC-Derived Hematoendothelial Progenitors and Specification Toward T cell Lineage
1个月前
已完结
Generating Single Positive CD8 T Cells from Induced Pluripotent Stem Cells
1个月前
已关闭
Autoimmune diseases: targets, biology, and drug discovery
1个月前
已完结
Erythrocyte patch for enhanced B cell depletion therapy
3个月前
已完结
Efficient gene expression in megakaryocytic cell line using nucleofection
5个月前
已完结
Advances and Challenges in the Ex Vivo Production of Megakaryocytes and Platelets
6个月前
已完结
Purification technologies for induced pluripotent stem cell therapies
7个月前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
11个月前
已完结
皖公网安备34019202002308
